ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 655072 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 655072; 2) Community: the network communities that were significantly associated with the response to NSC 655072; 3) Molecule: the relationships between components within communities and NSC 655072; 4) MDR: the compounds that were significantly associated with the NSC 655072.

NSC Compound Enrichment Correlation
NSC 603553 2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(4-methoxy phenyl)-, hydrochloride 0.0454469012959173 -0.071171903
NSC 610458 Camptothecin Derivative 0.0454469012959173 0.18390237
NSC 610459 Camptothecin Derivative 0.0454469012959173 0.13464632
NSC 619859 1H-3-Benzazepin-2-one, 2,3,4,5-tetrahydro-7,8-dimethoxy- 3-[(2,3-dimethoxyphenyl)methyl]-1-methylthio- 0.0454469012959173 0.066570377
NSC 621322 Null 0.0454469012959173 0.069464219
NSC 630511 1,4-Benzoquinone-2-methoxy-5-dimethylaminomethyl- 6-(10-heptadecenyl)-(Z)-, hydrochloride 0.0454469012959173 0.20775876
NSC 638646 4-Piperidinone, 3,5-bis[(3,4-dichlorophenyl)methylene]- 1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride 0.0454469012959173 0.27803516
NSC 652565 Null 0.0454469012959173 0.062350116
NSC 12097 Resorufine 0.0459335986102865 -0.10323491
NSC 155693 6H-Pyrido[4,3-b]carbazolium, 9-methoxy-2,5,11-trimethyl-,iodide 0.0459335986102865 -0.071646186
Total:39  Current:33    [First] [Prev] [Next] [Last]